Codexis, Inc. CDXS 深 沪
交易中 05-11 12:11:24 美东时间
2.67
-0.185
-6.48%
华盛通- 最 高2.98
- 今 开2.88
- 成交量 59.13万股
- 最 低 2.55
- 昨 收 2.855
- 总市值 1.74亿
- 52周最高 3.87
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.9583
- 委 比 -66.60%
- 总股本 6530.41万
- 历史最高 42.01
- 量 比 1.15
- 振 幅 15.06%
- 历史最低 0.9583
- 每 手 1
- 风险率 0.57%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Dow Tumbles Over 1%; US Weekly Jobless Claims Fall
U.S. stocks down, Dow falls 500+ points. Energy shares up 0.4%, financial stocks down 1.4%. Jobless claims decline to 213,000, trade deficit shrinks.
03-12 21:49
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers SciSparc (NASDAQ:SPRC) stock rose 35.1% to $5.2 during Thursday's pre-...
03-12 20:05
Preview: Codexis's Earnings
Codexis (NASDAQ:CDXS) is preparing to release its quarterly earnings on Wednesd...
03-11 01:01
Codexis Achieves ISO 9001:2015 Certification
Codexis Inc. (Nasdaq: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, announced today that it has earned its ISO 9001:2015 certification. The official certification
02-10 22:11
Earnings Scheduled For November 6, 2025
Companies Reporting Before The Bell • Clear Channel Outdoor (NYSE:CCO) is expec...
2025-11-06 19:12
Codexis to Participate in Jefferies Global Healthcare Conference
Codexis to attend Jefferies Global Healthcare Conference on June 3-5, 2025, with management participating in a fireside chat on June 4 at 3:10 pm ET. A live webcast and 90-day replay will be available on the company’s Investor Relations website.
2025-05-21 20:05
Cantor Fitzgerald Reiterates Overweight on Codexis, Maintains $11 Price Target
Cantor Fitzgerald analyst Kristen Kluska reiterates Codexis (NASDAQ:CDXS) with a Overweight and maintains $11 price target.
2024-09-21 00:03
